BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4022502)

  • 1. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.
    Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A
    Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors in ovarian epithelial carcinoma.
    Schwartz PE; LiVolsi VA; Hildreth N; MacLusky NJ; Naftolin FN; Eisenfeld AJ
    Obstet Gynecol; 1982 Feb; 59(2):229-38. PubMed ID: 7078869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progestin receptors in an ovarian ependymoma.
    Auerbach R; Mittal K; Schwartz PE
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.
    Bizzi A; Codegoni AM; Landoni F; Marelli G; Marsoni S; Spina AM; Torri W; Mangioni C
    Cancer Res; 1988 Nov; 48(21):6222-6. PubMed ID: 3167868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple parameter analyses of human ovarian cancer: morphology, immunohistochemistry, steroid hormone receptors and aromatase.
    Kühnel R; Rao BR; Poels LG; Delemarre JF; Kenemans P; Stolk JG
    Anticancer Res; 1988; 8(2):281-6. PubMed ID: 3364939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
    De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
    Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM; Holt JA; Lorincz MA; Herbst AL
    Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytosol receptor levels in malignant and benign ovarian tumors].
    Thurzó L; Falkay G; Sas M
    Orv Hetil; 1987 Aug; 128(36):1881-4, 1887. PubMed ID: 3658406
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen and progestin binding in cytosols of ovarian adenocarcinomas.
    Holt JA; Caputo TA; Kelly KM; Greenwald P; Chorost S
    Obstet Gynecol; 1979 Jan; 53(1):50-8. PubMed ID: 760018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome.
    Glaubitz LC; Bowen JH; Cox EB; McCarty KS
    Arch Pathol Lab Med; 1984 Jan; 108(1):27-30. PubMed ID: 6546333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative actions of tamoxifen to human ovarian carcinomas in vitro.
    Lazo JS; Schwartz PE; MacLusky NJ; Labaree DC; Eisenfeld AJ
    Cancer Res; 1984 Jun; 44(6):2265-71. PubMed ID: 6722767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas].
    Han LP; Dong ZM; Qiao YH; Nesland JM; Suo ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):606-10. PubMed ID: 16909613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.